NICOTINE
NDC 17856-0906, NICOTINE POLACRILEX, lozenge, from Atlantic Biologicals Corp..
- Product NDC
- 17856-0906
- Status
- Listed
- Labeler
- Atlantic Biologicals Corp.
- Dosage form
- LOZENGE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA213266
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/17856-0906 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NICOTINE4 mg/1
Pharmacologic classes
Cholinergic Nicotinic Agonist [EPC]; Nicotine [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 17856-0906-7 | 17856090607 | 47 POUCH in 1 BOX, UNIT-DOSE (17856-0906-7) / 1 LOZENGE in 1 POUCH |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 17856-0906 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/17856-0906 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 17856-0906. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.